Infectious Material. hazmat.dot.gov/regs/rules.htm iata.org/dangerousgoods

Size: px
Start display at page:

Download "Infectious Material. hazmat.dot.gov/regs/rules.htm iata.org/dangerousgoods"

Transcription

1 Infectious Material Most medical specimens sent to an esoteric laboratory such as Mayo Medical Laboratories are flown on passenger aircraft or are carried by common air carrier such as FedEx. The International Civil Aviation Organization (ICAO) and International Air Transport Association (IATA) have established stringent rules to protect passengers and package handlers from exposure to these potentially infectious substances. These regulations are enforced by the Federal Aviation Administration (FAA) or other similar enforcement agencies around the world who can levy significant fines against shippers and carriers who violate the regulations. You should be aware that your test send-out area is considered the shipper when they send specimens to a reference laboratory. Therefore, your send-out area must understand and follow regulations for shipping infectious substances affecting humans. It is the responsibility of the shipper to ensure correct identification, classification, packaging, labeling, marking, and documentation for all shipments of infectious substances. In addition, the shipper is responsible for ensuring that all persons involved in the transport of infectious substances receive the required initial and recurrent training. Information on these requirements can be found in the following Web sites: hazmat.dot.gov/regs/rules.htm iata.org/dangerousgoods We will focus on the regulations for shipping infectious substances by air. If you use a ground service, you must follow U.S. Department of Transportation (DOT) regulations. If you use the U.S. Postal Service, you must follow Post Office regulations. In either case, contact the Dangerous Goods Departments of the carrier you plan to use for details. IATA and ICAO have established 2 categories of specimens, Category A and Category B. 1,2 Both specimen types require specific packaging and handling procedures designed to protect anyone who comes in contact with the package. The shipper (your send-out staff) must decide in which category specimens belong. With the implementation of Universal Precautions, all blood and body fluids are considered potentially infectious. To clarify the situation for air transport, the regulators redefined Infectious Substances. Infectious substances are substances known to contain, or reasonably expected to contain, pathogens. 3 These specimens must be packaged as infectious substances, following IATA Packing Instruction On the other hand, specimens sent for diagnostic or investigational purposes are classified as biological substance, Category B. Similarly, most clinical laboratory tests (eg, sodium, thyroid-stimulating hormone) are considered Category B specimens. These specimens must be packaged following IATA Packing Instruction Note: For a list of Category A infectious substances, see TABLE 3.6.D below. Shipping Cultures of Microorganisms Aerobic and Anaerobic Bacteria, Mycobacteria, Fungi, and Yeast Use either of the following methods for isolating the organism for transportation (Agar plate is not acceptable.): Method A. Transfer organism to appropriate agar slant, broth, or anaerobic transport vial. Incubate agar slant or broth for 18 to 24 hours or until actively growing. Method B. Cut out a nickel-sized piece of the agar on which there is a colony of the organism to be tested. Place the agar in a screw-capped, sterile (serum) vial, and cap the vial tightly. Note: Organism must be in pure culture, actively growing. (Agar plate is not acceptable.) Mixed cultures will not be processed. Prepack the culture specimens for shipping using large Mayo Medical Laboratories infectious containers (Supply T146). Mayo Medical Laboratories procedure for prepacking the mailers is shown below. You may also use commercial packaging. Follow instructions carefully. Mayo Medical Laboratories general procedure is described below; a more detailed copy may be ordered from Mayo Medical Laboratories.

2 Mayo Medical Laboratories Procedure for Prepacking Infectious Specimens General Infectious Blood, Cultures, and Serum Under Universal Precautions, all specimens should be considered potentially infectious; however, not all specimens should be sent as Category A infectious substances. Your send-out staff must decide which specimens must be shipped as Category A infectious substances. If the name of the test you are sending to Mayo Medical Laboratories includes 1 of the pathogens listed in IATA Dangerous Goods Regulations TABLE 3.6.D, it should presumptively be considered Category A infectious. Of course, medical knowledge can override generalities. Some specimens may not be capable of transmitting disease. The judgement of your medical director should prevail. Regulators require that the technical name of a Category A infectious substance (eg, culture s name) must be on the Shipper s Declaration for Dangerous Goods form. This poses a problem when a specimen is being sent for identification; its name is unknown. We suggest it is better to send the specimen as Category A infectious, and enter the technical name on the Shipper s Declaration for Dangerous Goods form as Suspected Category A Infectious Substance. If the culture being sent is not listed in IATA TABLE 3.6.D, then it can legally be sent as a Category B infectious substance, eliminating the need to prepare a Shipper s Declaration for Dangerous Goods or to use a UN certified container with the Class 6 hazard label. Mayo Medical Laboratories policy is to treat ALL actively growing cultures with extra care and to transport them inside the large Mayo Medical Laboratories infectious mailer (Supply T146). The specimen bag, the Styrofoam lid, and the box must each have affixed to them a blue C label (Supply T549) which will alert the send-out laboratory, the courier, and the receiving laboratory that the box contains a culture. Please affix a blue C label to each specimen bag containing any culture, whether that culture is classified as Category A or as Category B. If you do not have a Mayo Medical Laboratories courier who picks up and ships your specimens for you, then we ask that you affix a blue C label on the Styrofoam lid and to the outside of the box as well.

3 Shipping Category A Infectious Specimens Once specimens are prepacked, they must be boxed for shipment. If you are using a commercially available infectious mailer, follow their instructions carefully. If you are using a Mayo Medical Laboratories mailer, someone must place the prepacked specimens into a certified Mayo Medical Laboratories shipping box for shipment. Mayo Medical Laboratories couriers have been trained to follow our standard procedures for shipping infectious substances. If your send-out area must ship the specimens themselves, be warned that the process requires the shipper to follow the Letter of the Law. We suggest that you contact Mayo Medical Laboratories for a copy of our Courier Procedure for Shipping Infectious Substances to Mayo Medical Laboratories. Preprinted documentation for shipping Mayo Medical Laboratories packages can also be obtained as needed. The basics of the infectious shipping procedure are shown below. Once the above labels are attached and documentation is completed, tender the box with a common carrier. If any part of the labeling or documentation is incorrect, the box will be returned on the next working day. BE SURE to complete every label and document correctly. Packages Damaged While in Transit to Mayo Medical Laboratories If a package leaks in transit, the carrier will first contact Mayo Medical Laboratories for instructions and then will notify: Centers for Disease Control and Prevention (CDC) Attn: Biohazards Control Office 1600 Clifton Road Northeast Atlanta, GA (phone: )

4 The carrier shall also notify the sender whose name appears on the infectious label and airbill. Carriers will insist on seeing the information in both places. TABLE 3.6.D Bacillus anthracis (cultures only) Brucella abortus (cultures only) Brucella melitensis (cultures only) Brucella suis (cultures only) Burkholderia mallei - Pseudomonas mallei - Glanders (cultures only) Burkholderia pseudomallei - Pseudomonas pseudomallei (cultures only) Chlamydia psittaci - avian strains (cultures only) Clostridium botulinum (cultures only) Coccidioides immitis (cultures only) Coxiella burnetii (cultures only) Crimean-Congo hemorrhagic fever virus Dengue virus (cultures only) Eastern equine encephalitis virus (cultures only) Ebola virus Escherichia coli, verotoxigenic (cultures only) Flexal virus Francisella tularensis (cultures only) Guanarito virus Hantaan virus Hantaviruses causing hemorrhagic fever with renal syndrome Hendra virus Hepatitis B virus (cultures only) Herpes B virus (cultures only) Human immunodeficiency virus (cultures only) Highly pathogenic avian influenza virus (cultures only) Japanese encephalitis virus (cultures only) Junin virus Kyasanur Forest disease virus Lassa virus Machupo virus Marburg virus Monkeypox virus Mycobacterium tuberculosis (cultures only) Nipah virus Omsk hemorrhagic fever virus Poliovirus (cultures only) Rabies virus (cultures only) Rickettsia prowazekii (cultures only) Rickettsia rickettsii (cultures only) Rift Valley fever virus (cultures only) Russian spring-summer encephalitis virus (cultures only) Sabia virus Shigella dysenteriae type 1 (cultures only) Tick-borne encephalitis virus (cultures only) Variola virus Venezuelan equine encephalitis virus (cultures only) West Nile virus (cultures only) Yellow fever virus (cultures only) Yersinia pestis (cultures only) References 1. Section 3 Classification, Dangerous Goods Regulations, 49th Edition, International Air Transport Association, Montreal- Geneva, 2008, pp Technical Instructions for the Safe Transport of Dangerous Goods by Air, International Civil Aviation Organization, Montreal, Quebec, Canada, Edition, pp to Infectious Substances, Section , Dangerous Goods Regulations, 49th Edition, International Air Transport Association, Montreal-Geneva, 2008, p Packing Instruction 602, Dangerous Goods Regulations, 49th Edition, International Air Transport Association, Montreal- Geneva, 2008, pp

5 5. Packing Instruction 650, Dangerous Goods Regulations, 49th Edition, International Air Transport Association, Montreal- Geneva, 2008, pp Shipper s Declaration for Dangerous Goods

STOP! These are some Symbols below that are Violations! PLEASE CHECK ALL SIX (6) SIDES OF YOUR BOX BEFORE SHIPPING

STOP! These are some Symbols below that are Violations! PLEASE CHECK ALL SIX (6) SIDES OF YOUR BOX BEFORE SHIPPING STOP! If you are reusing a box for shipping and the symbols below are printed ANYWHERE on the box Your AHDC label will be voided. Your package will be returned and you will be assessed a $50 shipping penalty

More information

Mount Sinai Medical Center Environmental Health & Safety (EnvHS)

Mount Sinai Medical Center Environmental Health & Safety (EnvHS) Mount Sinai Medical Center Environmental Health & Safety (EnvHS) Chemical / Infectious / Biological and Radiological Materials Shipment Approval Form I. GENERAL INFORMATION Shipment Date Requestor s Name

More information

Sample collection and shipping. disinfection

Sample collection and shipping. disinfection Sample collection and shipping Transport, biosafety and disinfection 2011 Learning objectives At the end of the presentation, participants should understand: d Principles of biosafety How to transport

More information

THE UNIVERSITY OF MISSISSIPPI LABORATORY SERVICES Phone (662) FAX (662)

THE UNIVERSITY OF MISSISSIPPI LABORATORY SERVICES Phone (662) FAX (662) THE UNIVERSITY OF MISSISSIPPI LABORATORY SERVICES Phone (662) 915-5433 FAX (662) 915-5480 CONSIGNMENT OF DIAGNOSTIC SPECIMENS The following note was developed by ICAO and issued 20th December 2002. The

More information

FEDERAL REGISTER Hazardous Materials: Infectious Substances; Harmonization With the United Nations Recommendations

FEDERAL REGISTER Hazardous Materials: Infectious Substances; Harmonization With the United Nations Recommendations GUIDE TO CHANGES EFFECTIVE OCTOBER 1, 2006 FEDERAL REGISTER Hazardous Materials: Infectious Substances; Harmonization With the United Nations Recommendations U.S. Department of Transportation Pipeline

More information

FEDERAL REGISTER Hazardous Materials: Infectious Substances; Harmonization With the United Nations Recommendations

FEDERAL REGISTER Hazardous Materials: Infectious Substances; Harmonization With the United Nations Recommendations GUIDE TO CHANGES EFFECTIVE OCTOBER 1, 2006 FEDERAL REGISTER Hazardous Materials: Infectious Substances; Harmonization With the United Nations Recommendations U.S. Department of Transportation Pipeline

More information

Guidance on regulations for the Transport of Infectious Substances

Guidance on regulations for the Transport of Infectious Substances Guidance on regulations for the Transport of Infectious Substances 2013-2014 1 - 2 3 GMOs GMMOs B B 4 P620 P650 5 )WHO( )document WHO/CDS/IHR/2010.8( 6 )UNCETDG( )modal( ICO )DGR( )ICO( )IT( ICO ICO IT

More information

TECHNICAL INSTRUCTIONS FOR THE SAFE TRANSPORT OF DANGEROUS GOODS BY AIR

TECHNICAL INSTRUCTIONS FOR THE SAFE TRANSPORT OF DANGEROUS GOODS BY AIR Doc 9284-AN/905 2005-2006 Edition ADDENDUM../02/05 INTERNATIONAL CIVIL AVIATION ORGANIZATION TECHNICAL INSTRUCTIONS FOR THE SAFE TRANSPORT OF DANGEROUS GOODS BY AIR 2005-2006 EDITION ADDENDUM The attached

More information

Yorkhill Laboratories Policy for the Packaging and Transport of Biological Samples (sent from laboratories) H&S/Doc/07. Yorkhill Hospitals

Yorkhill Laboratories Policy for the Packaging and Transport of Biological Samples (sent from laboratories) H&S/Doc/07. Yorkhill Hospitals Management Procedure Packaging and Transport of This document together with Standard Operating Procedures, instruction manuals, etc, forms part of, and is representative of the Quality Management System

More information

Our Directory of Services (DOS): /view/general/1496/

Our Directory of Services (DOS):  /view/general/1496/ Our Website: http://nmhealth.org/about/sld/ Our Directory of Services (DOS): http://nmhealth.org/publication /view/general/1496/ WEBSITE AND DIRECTORY OF SERVICES Contact Information: TITLE PHONE/FAX COMMENTS

More information

SCHEDULE 5 PATHOGENS AND TOXINS VIRUSES

SCHEDULE 5 PATHOGENS AND TOXINS VIRUSES 10/2012 SCHEDULE 5 PATHOGENS AND TOXINS VIRUSES Chikungunya virus Congo- crimean haemorrhagic fever virus Dengue fever virus Dobrava/Belgrade virus Eastern equine encephalitis virus Ebola virus Everglades

More information

Dangerous Goods Regulations

Dangerous Goods Regulations .6.2 Division 6.2 Infectious.6.2.2 Classification of Infectious Substances Substances STATE VARIATIONS: AUG 0, CAG 08, VUG 02.6.2.2.1 Infectious substances must be classified in Division 6.2 and assigned

More information

Cal OSHA Title 8, Section 5199 Appendix D: Aerosol Transmissible Pathogens Laboratory

Cal OSHA Title 8, Section 5199 Appendix D: Aerosol Transmissible Pathogens Laboratory Cal OSHA Title 8, Section 5199 Appendix D: Aerosol Transmissible Pathogens Laboratory This appendix contains a list of agents that, when reasonably anticipated to be present, require a laboratory to comply

More information

Dr. Jim LeDuc Director Galveston National Laboratory University of Texas Medical Branch. 29 October 2015

Dr. Jim LeDuc Director Galveston National Laboratory University of Texas Medical Branch. 29 October 2015 National Academy of Sciences Committee on Federal Regulations and Reporting Requirements: A new framework for research universities in the 21 st Century Select Agents Dr. Jim LeDuc Director Galveston National

More information

Classification of Infectious Substances. Substances

Classification of Infectious Substances. Substances .6.2 Division 6.2 Infectious Substances.6.2.2 Classification of Infectious Substances STATE VARIATIONS: AUG 0, CAG 08, VUG 02.6.2.2.1 Infectious substances must be classified in Division 6.2 and assigned

More information

University of Hawaii Biosafety Program Laboratory Inventory and Declaration Form

University of Hawaii Biosafety Program Laboratory Inventory and Declaration Form ANNUAL MICROORGANISM INVENTORY DECLARATION FORM (Part A) The principal investigator for each laboratory working with microorganisms, including select agent toxins must complete this form on an annual basis.

More information

secondary packaging, but sufficient additional absorbent material shall be used to absorb all fluid in case of breakage.

secondary packaging, but sufficient additional absorbent material shall be used to absorb all fluid in case of breakage. The transport of infectious substances is covered by international regulations that are updated on a regular basis and are widely accessible via the internet, or through commercial and regulatory transportation

More information

Institutional Laboratory Biosafety Manual

Institutional Laboratory Biosafety Manual Appendix B. Select Agents and Toxins The Centers for Disease Control and Prevention (CDC) and the Animal and Plant Health Inspection Service (APHIS) oversee the possession, use and transfer of select agents

More information

Agents of Bioterrorism: Argument for and Against a List That Needs Cropping

Agents of Bioterrorism: Argument for and Against a List That Needs Cropping Agents of Bioterrorism: Argument for and Against a List That Needs Cropping Bioterrorism Preparedness: A Conference for Senior Practitioners and Professionals Dr. Arnold N. Weinberg Professor of Medicine

More information

Transport of Infectious Substances

Transport of Infectious Substances Transport of Infectious Substances Background to the amendments adopted in the 13 th revision of the United Nations Model Regulations guiding the transport of infectious substances 2004 Department of Communicable

More information

SELECT BIOLOGICAL AGENTS POLICY

SELECT BIOLOGICAL AGENTS POLICY SELECT BIOLOGICAL AGENTS POLICY Overview The purpose of this policy is to provide guidance in complying with statutes concerning special biological agents and toxins known to be potential terrorist agents

More information

Regulations. Bloodborne Pathogens. Applicability. Biological Agents and Blood borne Pathogens

Regulations. Bloodborne Pathogens. Applicability. Biological Agents and Blood borne Pathogens Regulations Biological Agents and Blood borne Pathogens OSHA 29CFR1910.1030 (1989 2004) Exposure to blood and blood products and other potentially infectious material (OPIM) Definition of OPIM-human body

More information

Bioterrorism and Biosecurity in the United States

Bioterrorism and Biosecurity in the United States Bioterrorism and Biosecurity in the United States Jennifer Gaudioso, Ph.D. Sandia National Laboratories Seminar on Prevention and Crisis Management of Bioterrorism Southeast Asia Regional Centre for Counter-Terrorism,

More information

Pathogens and Toxins Guidance. ATCSA 2001 Schedule 5 Order 2007 Notes (SI 2007/929)

Pathogens and Toxins Guidance. ATCSA 2001 Schedule 5 Order 2007 Notes (SI 2007/929) Pathogens and Toxins Guidance ATCSA 2001 Schedule 5 Order 2007 tes (SI 2007/929) Guidance on tes 1a - d of the Schedule 5 to the Anti-Terrorism, Crime and Security Act 2001 (Modification) Order 2007 (2007/929)

More information

Plant Pathogen Select Agents: Revised Rule Biocontainment Requirements

Plant Pathogen Select Agents: Revised Rule Biocontainment Requirements Plant Pathogen Select Agents: Revised Rule Biocontainment Requirements Charles Divan Assistant Director Agriculture Select Agent Program Animal and Plant Health Inspection Service Plant Protection and

More information

Ethic Problems Related to the Microorganisms

Ethic Problems Related to the Microorganisms "Bioethics in Life and Environmental Sciences" Lublin 22 March 05 April 2009 Ethic Problems Related to the Microorganisms Prof. Iskra Ivanova Sofia University St. Kliment Ohridski Faculty of Biology, Department

More information

Infectious Diseases Weekly Report. 14 March 2013 / Number 10

Infectious Diseases Weekly Report. 14 March 2013 / Number 10 Infectious Diseases Weekly Report TOKYOIDWR Tokyo Metropolitan Infectious Disease Surveillance Center 14 March / Number 10 Surveillance System in Tokyo, Japan The infectious diseases which all physicians

More information

Infectious Diseases Weekly Report. 12 January 2018 / Number 1. The infectious diseases which all physicians must report

Infectious Diseases Weekly Report. 12 January 2018 / Number 1. The infectious diseases which all physicians must report Infectious Diseases Weekly Report TOKYOIDWR Tokyo Metropolitan Infectious Disease Surveillance Center 12 January / Number 1 Surveillance System in Tokyo, Japan The infectious diseases which all physicians

More information

Infectious Diseases Weekly Report. 23 August 2018 / Number 33. The infectious diseases which all physicians must report

Infectious Diseases Weekly Report. 23 August 2018 / Number 33. The infectious diseases which all physicians must report Infectious Diseases Weekly Report TOKYOIDWR Tokyo Metropolitan Infectious Disease Surveillance Center 23 August / Number 33 Surveillance System in Tokyo, Japan The infectious diseases which all physicians

More information

Infectious Diseases Weekly Report. 8 November 2018 / Number 44. The infectious diseases which all physicians must report

Infectious Diseases Weekly Report. 8 November 2018 / Number 44. The infectious diseases which all physicians must report Infectious Diseases Weekly Report TOKYOIDWR Tokyo Metropolitan Infectious Disease Surveillance Center 8 November / Number 44 Surveillance System in Tokyo, Japan The infectious diseases which all physicians

More information

Infectious Diseases Weekly Report. 15 November 2018 / Number 45. The infectious diseases which all physicians must report

Infectious Diseases Weekly Report. 15 November 2018 / Number 45. The infectious diseases which all physicians must report Infectious Diseases Weekly Report TOKYOIDWR Tokyo Metropolitan Infectious Disease Surveillance Center 15 November / Number 45 Surveillance System in Tokyo, Japan The infectious diseases which all physicians

More information

Infectious Diseases Weekly Report. 14 March 2019 / Number 10. The infectious diseases which all physicians must report

Infectious Diseases Weekly Report. 14 March 2019 / Number 10. The infectious diseases which all physicians must report Infectious Diseases Weekly Report TOKYOIDWR Tokyo Metropolitan Infectious Disease Surveillance Center 14 March / Number 10 Surveillance System in Tokyo, Japan The infectious diseases which all physicians

More information

Infectious Diseases Weekly Report. 22 March 2019 / Number 11. The infectious diseases which all physicians must report

Infectious Diseases Weekly Report. 22 March 2019 / Number 11. The infectious diseases which all physicians must report Infectious Diseases Weekly Report TOKYOIDWR Tokyo Metropolitan Infectious Disease Surveillance Center 22 March / Number 11 Surveillance System in Tokyo, Japan The infectious diseases which all physicians

More information

Infectious Diseases Weekly Report. 28 March 2019 / Number 12. The infectious diseases which all physicians must report

Infectious Diseases Weekly Report. 28 March 2019 / Number 12. The infectious diseases which all physicians must report Infectious Diseases Weekly Report TOKYOIDWR Tokyo Metropolitan Infectious Disease Surveillance Center 28 March / Number 12 Surveillance System in Tokyo, Japan The infectious diseases which all physicians

More information

Infectious Diseases Weekly Report. 4 April 2019 / Number 13. The infectious diseases which all physicians must report

Infectious Diseases Weekly Report. 4 April 2019 / Number 13. The infectious diseases which all physicians must report Infectious Diseases Weekly Report TOKYOIDWR Tokyo Metropolitan Infectious Disease Surveillance Center 4 April / Number 13 Surveillance System in Tokyo, Japan The infectious diseases which all physicians

More information

Infectious Diseases Weekly Report. 11 April 2019 / Number 14. The infectious diseases which all physicians must report

Infectious Diseases Weekly Report. 11 April 2019 / Number 14. The infectious diseases which all physicians must report Infectious Diseases Weekly Report TOKYOIDWR Tokyo Metropolitan Infectious Disease Surveillance Center 11 April / Number 14 Surveillance System in Tokyo, Japan The infectious diseases which all physicians

More information

Interstate Shipment of Etiologic Agents 42 CFR Part 72

Interstate Shipment of Etiologic Agents 42 CFR Part 72 Interstate Shipment of Etiologic Agents 42 CFR Part 72 Federal Register, Vol. 45, No. 141-Monday, July 21, 1980. Part 72-Interstate Shipment of Etiologic Agents 1 Centers for Disease Control and Prevention

More information

INTERfering and Co-Evolving Prevention and Therapy (INTERCEPT) Proposers Day

INTERfering and Co-Evolving Prevention and Therapy (INTERCEPT) Proposers Day INTERfering and Co-Evolving Prevention and Therapy (INTERCEPT) Proposers Day Dr. Jim Gimlett, Program Manager DARPA Biological Technologies Office (BTO) April 28, 2016 Arlington, VA INTERCEPT Agenda INTERCEPT

More information

INTRODUCTORY CHAPTERS SAMPLING METHODS

INTRODUCTORY CHAPTERS SAMPLING METHODS 1 2 SECTION I.1 INTRODUCTORY CHAPTERS 3 4 CHAPTER I.1.1. SAMPLING METHODS 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 INTRODUCTION The starting point for the laboratory investigation of

More information

Index. Infect Dis Clin N Am 20 (2006) Note: Page numbers of article titles are in boldface type.

Index. Infect Dis Clin N Am 20 (2006) Note: Page numbers of article titles are in boldface type. Infect Dis Clin N Am 20 (2006) 475 483 Index Note: Page numbers of article titles are in boldface type. A Abortion storms, 363 Adult intestinal toxemia botulism, 317 Allergen Pharmaceuticals, 315 Alphaviruses

More information

Notes from the Sentinel Liaison

Notes from the Sentinel Liaison ADPH Unplugged Notes from the Sentinel Liaison Thank you for participating! Survey ListServ Notes Trainings Sentinel Training August 9-10, 2017 Packaging and Shipping September 14,2017 You can be a Sentinel

More information

Fort Detrick Area B11 Removal Action Update

Fort Detrick Area B11 Removal Action Update Area B11 Removal Action Update US Army Corps Restoration Advisory Board Meeting 13 February 2002, 7:30 PM Frederick, Maryland Excavation of overburden material completed and clean soil moved to Area B

More information

Federal Select Agent Program Overview

Federal Select Agent Program Overview Centers for Disease Control and Prevention Center for Preparedness and Response Federal Select Agent Program Overview Samuel S. Edwin, Ph.D. Director, Division of Select Agents and Toxins Boston Public

More information

Before you begin, in order to conserve your efforts, notify/contact Don Michael Hooks, Office of Environmental Health & Safety (EHS),

Before you begin, in order to conserve your efforts, notify/contact Don Michael Hooks, Office of Environmental Health & Safety (EHS), IBRDSC Policy Shipment of Biological Materials Before you begin, in order to conserve your efforts, notify/contact Don Michael Hooks, Office of Environmental Health & Safety (EHS), 225-578- 8498. Table

More information

Overview of Export Controlled pathogens and toxins.

Overview of Export Controlled pathogens and toxins. Overview of Export Controlled pathogens and toxins. Updated: April 5, 2018 This list is derived from the US Bureau of Industry and Security s (BIS) Commerce Control List. Exports of pathogens, toxins,

More information

"Wanted Poster" Diseases

Wanted Poster Diseases "Wanted Poster" Diseases Part One - Choosing a Disease Listed below are several bacteria and the disease they cause. Pick any one bacteria/disease to research. It is highly recommended that you pick a

More information

PART 1 GENERAL INFORMATION. OIE Terrestrial Manual

PART 1 GENERAL INFORMATION. OIE Terrestrial Manual PART 1 GENERAL INFORMATION OIE Terrestrial Manual 2008 1 SECTION 1.1. INTRODUCTORY CHAPTERS CHAPTER 1.1.1. COLLECTION AND SHIPMENT OF DIAGNOSTIC SPECIMENS INTRODUCTION The starting point for the laboratory

More information

Occupational Health Program Guidance Document for Working with Tier 1 Select Agents and Toxins

Occupational Health Program Guidance Document for Working with Tier 1 Select Agents and Toxins Occupational Health Program Guidance Document for Working with Tier 1 Select Agents and Toxins 7 CFR Part 331, 9 CFR Part 121, 42 CFR Part 73 05 July 2013 Centers for Disease Control and Prevention (CDC)

More information

Appendix B: Provincial Case Definitions for Reportable Diseases

Appendix B: Provincial Case Definitions for Reportable Diseases Infectious Diseases Protocol Appendix B: Provincial Case Definitions for Reportable Diseases Disease: Hemorrhagic fevers caused by: i) Ebola virus and ii) Marburg virus and iii) Other viral causes including

More information

Economic and Social Council

Economic and Social Council UNITED NATIONS E Economic and Social Council Distr. GENERAL TRANS/WP.15/AC.1/94/Add.2 10 November 2003 ENGLISH ORIGINAL : ENGLISH AND FRENCH ECONOMIC COMMISSION FOR EUROPE INLAND TRANSPORT COMMITTEE Working

More information

CBEP Biosciences Fellowship Program Program Summary

CBEP Biosciences Fellowship Program Program Summary Program Goal CBFP CBEP Biosciences Fellowship Program Program Summary To promote biological safety and security (BS&S) by increasing technical capacity for biological scientists in the Middle East and

More information

CTR Biosciences Fellowship Program Program Summary. Laboratory operations, research, and diagnostics.

CTR Biosciences Fellowship Program Program Summary. Laboratory operations, research, and diagnostics. Program Goal Application Deadline 4 January 2019 Who Should Apply CBFP CTR Biosciences Fellowship Program Program Summary To promote biological safety and security (BS&S) by increasing technical capacity

More information

Yale Environmental Health & Safety Update Form for Request to Use Infectious Agents Status of Protocol

Yale Environmental Health & Safety Update Form for Request to Use Infectious Agents Status of Protocol Yale Environmental Health & Safety Update Form for Request to Use Infectious Agents To update or renew the attached infectious agent registration please review the registration and complete the information

More information

The German Law on Prevention and Control of Communicable Diseases (Infektionsschutzgesetz)- Surveillance System. Michael H. Kramer

The German Law on Prevention and Control of Communicable Diseases (Infektionsschutzgesetz)- Surveillance System. Michael H. Kramer The German Law on Prevention and Control of Communicable Diseases (Infektionsschutzgesetz)- Surveillance System VHPB - Meeting, Berlin, Germany, 13-14 October 2003 Michael H. Kramer Federal Ministry of

More information

Implementation Manual for the National Epidemiological Surveillance of Infectious Diseases Program

Implementation Manual for the National Epidemiological Surveillance of Infectious Diseases Program Implementation Manual for the National Epidemiological Surveillance of Infectious Diseases Program Part I. Purpose and Aim The National Epidemiological Surveillance of Infectious Diseases (NESID) Program

More information

BIOTERRORISM DISEASES / AGENTS: A Visual Guide for US Air Force Public Health Officers

BIOTERRORISM DISEASES / AGENTS: A Visual Guide for US Air Force Public Health Officers BIOTERRORISM DISEASES / AGENTS: A Visual Guide for US Air Force Public Health Officers Compiled by: Michael J. Cuomo, Captain, USAF, BSC Columbus Air Force Base, MS (AETC) Contents: Anthrax (Bacillus anthracis)

More information

LABORATORY ALERT: Ebola Virus Disease (EVD)

LABORATORY ALERT: Ebola Virus Disease (EVD) County of Santa Clara Public Health Department Public Health Laboratory 2220 Moorpark Avenue, 2 nd Floor San José, CA 95128 408.885.4272 DATE: August 21, 2014 LABORATORY ALERT: Ebola Virus Disease (EVD)

More information

Viral Hemorrhagic Fevers CDC, AFIP

Viral Hemorrhagic Fevers CDC, AFIP CDC, AFIP Diverse group of illnesses caused by RNA viruses from 4 families: Arenaviridae, Bunyaviridae, Filoviridae, Flaviridae Differ by geographic occurrence and vector/reservoir Share certain clinical

More information

Present State and Measures against Infectious Diseases in Tokyo

Present State and Measures against Infectious Diseases in Tokyo Asian Network of Major Cities 21 Asian Infectious Disease Project Present State and Measures against Infectious Diseases in History of Law on Infectious Diseases Revisions 1897 1999 23 Communicable Disease

More information

Selected New Jersey Communicable Disease Regulations

Selected New Jersey Communicable Disease Regulations COMMUNICABLE DISEASE OUTBREAK MANUAL New Jersey s Public Health Response Selected New Jersey Communicable Disease Regulations June 2013 Public Health Emergency Response Capability Requirements as stated

More information

Food Defense: The Necessity of Its Implementation in Indonesia

Food Defense: The Necessity of Its Implementation in Indonesia Food Defense: The Necessity of Its Implementation in Indonesia Dedi Fardiaz Department of Food Science and Technology, and SEAFAST CENTER BOGOR AGRICULTURAL UNIVERSITY Food Defense - the protection of

More information

Definitions. As used in K.A.R through , each of the following terms

Definitions. As used in K.A.R through , each of the following terms 28-1-1. Definitions. As used in K.A.R. 28-1-1 through 28-1-23, each of the following terms shall have the meaning specified in this regulation: (a) Case means an instance of a suspected or diagnosed infectious

More information

routine blood cultures. RT Blood Culture Bottles routine blood cultures. RT Blood Culture Bottles of disease

routine blood cultures. RT Blood Culture Bottles routine blood cultures. RT Blood Culture Bottles of disease Updated: 7/20/2015 DISEASE/ Cutaneous NPHL Quick Reference Guide to Specimen Collection of Suspected Agents of Bioterrorism & Emerging Infectious Diseases All potential agents, if not ruled out must be

More information

NIAID Biodefense Research Agenda

NIAID Biodefense Research Agenda NIAID Biodefense Research Agenda Deborah G. Katz, M.S., R.N. Deputy Director Office of Biodefense Research Affairs National Institute of Allergy and Infectious Diseases Princeton University September 8,

More information

Animal and Zoonotic Disease Surveillance Systems: FAO/OIE/WHO Global Early Warning and Response System (GLEWS)

Animal and Zoonotic Disease Surveillance Systems: FAO/OIE/WHO Global Early Warning and Response System (GLEWS) Animal and Zoonotic Disease Surveillance Systems: FAO/OIE/WHO Global Early Warning and Response System (GLEWS) International Meeting on Emerging Diseases and Surveillance 2007 Legal frameworks Animal diseases:

More information

Biological Warfare Agents

Biological Warfare Agents Biological Warfare Agents Chapter 29 Biological Warfare Agents The reader is strongly advised to supplement material in this chapter with the following reference: US Army Medical Research Institute of

More information

Biological Warfare Agents

Biological Warfare Agents Chapter 29 The reader is strongly advised to supplement material in this chapter with the following reference: US Army Medical Research Institute of Infectious Diseases (USAMRIID). Medical Management of

More information

Infectious Disease Control Law of Japan and Biorisk management in NIID NIID 国立感染症研究所. July 10, 2008, Seoul, Korea

Infectious Disease Control Law of Japan and Biorisk management in NIID NIID 国立感染症研究所. July 10, 2008, Seoul, Korea Infectious Disease Control Law of Japan and Biorisk management in NIID July 10, 2008, Seoul, Korea NIID 国立感染症研究所 Kazuyoshi SUGIYAMA National Institute of Infectious Diseases Division of Biosafety Control

More information

Animal Disease Surveillance in South Africa. Submitted by South Africa

Animal Disease Surveillance in South Africa. Submitted by South Africa MEETING OF THE STATES PARTIES TO THE CONVENTION ON THE PROHIBITION OF THE DEVELOPMENT, PRODUCTION AND STOCKPILING OF BACTERIOLOGICAL (BIOLOGICAL) AND TOXIN WEAPONS AND ON THEIR DESTRUCTION 15 July 2004

More information

Arbovirus Surveillance: Present and Future

Arbovirus Surveillance: Present and Future Arbovirus Surveillance: Present and Future Duane J Gubler, ScD, FAAAS, FIDSA, FASTMH Emeritus Professor Program in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore, Chairman, Global Dengue

More information

Net EOP Table of Contents Biological 1

Net EOP Table of Contents Biological 1 Net EOP Table of Contents Biological 1 MONTGOMERY COUNTY, KANSAS EMERGENCY OPERATIONS PLAN Incident Annex - Biological Preface Coordinating Agency: Cooperating Agencies: Montgomery County Health Department

More information

CHAPTER 515. COMMUNICABLE DISEASE AND INJURY REPORTING EFFECTIVE 9/12/2014

CHAPTER 515. COMMUNICABLE DISEASE AND INJURY REPORTING EFFECTIVE 9/12/2014 TITLE 310. CHAPTER 515. COMMUNICABLE DISEASE AND INJURY REPORTING EFFECTIVE 9/12/2014 310:515-1-1. Purpose The rules in this Chapter implement the Communicable Diseases Reporting Regulations, 63 O.S. 1981,

More information

WHAT WILL WE LEARN FROM ESEI RESEARCH?

WHAT WILL WE LEARN FROM ESEI RESEARCH? WHAT WILL WE LEARN FROM ESEI RESEARCH? Mark Woolhouse University of Edinburgh WHAT WILL WE LEARN FROM ESEI RESEARCH? Dealing with diverse disease ecologies Diversity and generalisation Endemic diseases

More information

HPSC - Weekly Infectious Disease Report

HPSC - Weekly Infectious Disease Report HPSC - Weekly Infectious Disease Report Statutory Notifications of Infectious Diseases reported in Ireland via the Computerised Infectious Disease Reporting (CIDR) system for: Week 22, 2018 (Notification

More information

HPSC - Weekly Infectious Disease Report

HPSC - Weekly Infectious Disease Report HPSC - Weekly Infectious Disease Report Statutory Notifications of Infectious Diseases reported in Ireland via the Computerised Infectious Disease Reporting (CIDR) system for: Week 49, 2018 (Notification

More information

HPSC - Weekly Infectious Disease Report

HPSC - Weekly Infectious Disease Report HPSC - Weekly Infectious Disease Report Statutory Notifications of Infectious Diseases reported in Ireland via the Computerised Infectious Disease Reporting (CIDR) system for: Week 33, 2018 (Notification

More information

HPSC - Weekly Infectious Disease Report

HPSC - Weekly Infectious Disease Report HPSC - Weekly Infectious Disease Report Statutory Notifications of Infectious Diseases reported in Ireland via the Computerised Infectious Disease Reporting (CIDR) system for: Week 50, 2018 (Notification

More information

HPSC - Weekly Infectious Disease Report

HPSC - Weekly Infectious Disease Report HPSC - Weekly Infectious Disease Report Statutory Notifications of Infectious Diseases reported in Ireland via the Computerised Infectious Disease Reporting (CIDR) system for: Week 39, 2018 (Notification

More information

A Survey of Asian Life Scientists: The State of Biosciences, Laboratory Biosecurity, and Biosafety in Asia

A Survey of Asian Life Scientists: The State of Biosciences, Laboratory Biosecurity, and Biosafety in Asia SANDIA REPORT SAND2006-0842 Unlimited Release Printed February 2006 A Survey of Asian Life Scientists: The State of Biosciences, Laboratory Biosecurity, and Biosafety in Asia Sandia National Laboratories

More information

HPSC - Weekly Infectious Disease Report

HPSC - Weekly Infectious Disease Report HPSC - Weekly Infectious Disease Report Statutory Notifications of Infectious Diseases reported in Ireland via the Computerised Infectious Disease Reporting (CIDR) system for: Week 38, 2018 (Notification

More information

HPSC - Weekly Infectious Disease Report

HPSC - Weekly Infectious Disease Report HPSC - Weekly Infectious Disease Report Statutory Notifications of Infectious Diseases reported in Ireland via the Computerised Infectious Disease Reporting (CIDR) system for: Week 3, 2019 (Notification

More information

BACTERIOLOGY PROGRAMME AND PLAN OF TEACHING 3 rd Semester (academic year )

BACTERIOLOGY PROGRAMME AND PLAN OF TEACHING 3 rd Semester (academic year ) BACTERIOLOGY PROGRAMME AND PLAN OF TEACHING 3 rd Semester (academic year 2012-2013) 19. 10. 2012. Introduction in microbiology, bacterial taxonomy, general bacterial prop Bacterial structures, biosynthesis

More information

Prof. Dr. Reinhard Burger Robert Koch-Institut

Prof. Dr. Reinhard Burger Robert Koch-Institut Berlin-Marienfelde, 25. März 2004 Fortbildungsveranstaltung für den Öffentlichen Gesundheitsdienst 2004 Aktuelle Entwicklungen in Infektionsschutz- und Bioterrorismus- Prävention Prof. Dr. Reinhard Burger

More information

Guidance Document Infectious Substances

Guidance Document Infectious Substances Guidance Document Infectious Substances Note: 1. The following Guidance Document was developed by the ICAO DGP. The original ICAO document reflects references to the ICAO Technical Instructions these have

More information

Why Infectious Waste is Regulated To minimize the potential for the spread of disease from a medical setting to the general public; and To reduce the

Why Infectious Waste is Regulated To minimize the potential for the spread of disease from a medical setting to the general public; and To reduce the Infectious Medical Waste Information Guidance on Segregation of Wastes and Waste Reduction Why Infectious Waste is Regulated To minimize the potential for the spread of disease from a medical setting to

More information

COMMUNICATING IN A CRISIS

COMMUNICATING IN A CRISIS NEWS &TERRORISM COMMUNICATING IN A CRISIS A fact sheet from the National Academies and the U.S.Department of Homeland Security BIOLOGICAL ATTACK HUMAN PATHOGENS, BIOTOXINS, AND AGRICULTURAL THREATS Communication

More information

Microbiology Collection

Microbiology Collection Microbiology Collection Notify the Microbiology Laboratory at 920-738-6317 if any of the following etiological agents are suspected to be present in the specimens sent to the laboratory. Bacillius anthracis

More information

Labs- automated ELR Labs reporting manually Health care providers. immediate within 7 days. immediate within 7 days. immediate within 7 days.

Labs- automated ELR Labs reporting manually Health care providers. immediate within 7 days. immediate within 7 days. immediate within 7 days. Immediate Notification: Douglas Co. (402)444-7214 (after hrs 402-444-7000) Lancaster Co (402) 441-8056 (or page 402-790-6357) All Other Counties - Call Local County Health Dept AND State Epi at 402-471-1983

More information

One World One Health TM

One World One Health TM One World One Health TM AVIAN INFLUENZA: INTERSECTORAL COLLABORATION Larnaca, Cyprus 20 22 July 2009 Kate Glynn DVM, MPVM Scientific and Technical Department One World, One Health TM 2004 : Manhattan Principles

More information

Massachusetts Department of Public Health Bureau of Communicable Disease Control Office of Integrated Surveillance and Informatics Services (ISIS)

Massachusetts Department of Public Health Bureau of Communicable Disease Control Office of Integrated Surveillance and Informatics Services (ISIS) Massachusetts Department of Public Health Bureau of Communicable Disease Control Office of Integrated Surveillance and Informatics Services (ISIS) Summary of Amendments to 105 CMR 300.000: Reportable Diseases,

More information

Transportation and Handling of Biological products in the Middle East. Dr. Ghazi Yehia Regional Representative for the Middle East

Transportation and Handling of Biological products in the Middle East. Dr. Ghazi Yehia Regional Representative for the Middle East Transportation and Handling of Biological products in the Middle East Dr. Ghazi Yehia Regional Representative for the Middle East Introduction In a world that has complicated routes and means of transportation,

More information

Infectious Disease Update 2011

Infectious Disease Update 2011 Faculty Infectious Disease Update 2011 Mary G. McIntyre, MD, MPH Assistant State Health Officer Disease Control and Prevention Alabama Department of Public Health Satellite Conference and Live Webcast

More information

Monitoring the Health of Transplanted Organs DONOR GENOTYPING MANUAL

Monitoring the Health of Transplanted Organs DONOR GENOTYPING MANUAL Monitoring the Health of Transplanted Organs DONOR GENOTYPING MANUAL 10101 Innovation Drive. Suite 600. Wauwatosa, WI 53226 1-888-214-3151 MKT-008 v3.0 MKT-008 v3.0 TABLE OF CONTENTS I Intended Use...

More information

Bioterrorism Capabilities in Rural Texas Hospitals and Laboratories by

Bioterrorism Capabilities in Rural Texas Hospitals and Laboratories by Bioterrorism Capabilities in Rural Texas Hospitals and Laboratories by Taylor M. Johnson Public Health Internship Program School of Biological Sciences The University of Texas at Austin Mentor: Dr. Grace

More information

Section 1 has been repealed by Decree of 30 December 2003/1383.

Section 1 has been repealed by Decree of 30 December 2003/1383. Ministry of Social Affairs and Health, Finland Unofficial translation No. 786/1986 Communicable Diseases Decree Issued on 31 October 1986 Section 1 has been repealed by Decree of 30 December 2003/1383.

More information

List of ALARMING Diagnoses

List of ALARMING Diagnoses List of ALARMING Diagnoses Diagnosis Code Diagnosis Diagnosis Type Eligible for Incentive/Tier 584 (!) ANTHRAX C requires a clinically compatible illness plus laboratory confirmation via culture, nucleic

More information

A BSL-1 lab houses activities that require only standard microbial practices. These include:

A BSL-1 lab houses activities that require only standard microbial practices. These include: BSL-1 A BSL-1 lab houses activities that require only standard microbial practices. These include: Work should be performed on an open lab bench or table Spills must be decontaminated immediately Infectious

More information

Events detected by national surveillance system (see Annex 1)

Events detected by national surveillance system (see Annex 1) WHA58.3 ANNEX 2 DECISION INSTRUMENT FOR THE ASSESSMENT AND NOTIFICATION OF EVENTS THAT MAY CONSTITUTE A PUBLIC HEALTH EMERGENCY OF INTERNATIONAL CONCERN Events detected by national surveillance system

More information

BTSF. Better Training for Safer Food. Initiative. Sampling protocols and biosecurity measures. Geneviève LIBEAU. Peste des Petits Ruminants (PPR)

BTSF. Better Training for Safer Food. Initiative. Sampling protocols and biosecurity measures. Geneviève LIBEAU. Peste des Petits Ruminants (PPR) Better Training for Safer Food Sampling protocols and biosecurity measures Geneviève LIBEAU Initiative Peste des Petits Ruminants (PPR) This presentation is delivered under contract with the Consumers,

More information